Streetbeat News

Analyst Ratings

ETN

In the past three months, 4 analysts have provided ratings for Eaton Corp (NYSE:ETN), ranging from bullish to indifferent. The average 12-month price target has increased by 4.36% to $349.25. Analysts from Barclays, Jefferies, and Raymond James have raised their price targets, reflecting positive sentiment towards Eaton Corp's financial performance and market position.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 5:04 pm

IR

Ingersoll Rand (NYSE:IR) has received mixed analyst ratings over the past quarter, with a majority being somewhat bullish. The average 12-month price target has increased slightly to $105.62. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

August 02, 2024 | 5:03 pm

CLAR

Roth MKM analyst Matt Koranda has downgraded Clarus (NASDAQ:CLAR) from Buy to Neutral and lowered the price target from $7.5 to $6.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 5:03 pm

ITGR

Benchmark analyst Robert Wasserman has reiterated a Buy rating on Integer Holdings (NYSE:ITGR) and maintained a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 5:01 pm

W

Goldman Sachs analyst Alexandra Steiger maintains a Neutral rating on Wayfair (NYSE:W) but lowers the price target from $67 to $54.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 5:01 pm

MCD

MSFT

NVDA

RIG

The CNBC Halftime Report highlighted final trades including McDonald's, Microsoft, NVIDIA, and Transocean. These companies are expected to see short-term impacts based on the recommendations made during the segment.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 5:00 pm

QURE

Goldman Sachs analyst Salveen Richter maintains a Neutral rating on uniQure (NASDAQ:QURE) and raises the price target from $6 to $10.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 5:00 pm

RARE

Goldman Sachs analyst Salveen Richter maintains a Buy rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and raises the price target from $67 to $76.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 4:59 pm

ACLS

Benchmark analyst Mark Miller maintains a Buy rating on Axcelis Technologies (NASDAQ:ACLS) but lowers the price target from $180 to $175.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 4:58 pm

TRGP

Goldman Sachs has maintained its Buy rating on Targa Resources (NYSE:TRGP) and raised the price target from $132 to $147.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 4:58 pm